Zhejiang Provincial Drug Administration Provides Precise Services to Assist the Development of Silk Medical Devices
On January 13, 2022, a delegation of leaders and experts, including Comrade Dong Geng, Director of Drug Safety at the Zhejiang Provincial Drug Administration (hereinafter referred to as the Provincial Drug Administration), Comrade Dai Guiping, Director of the Medical Device Supervision and Management Division of the Provincial Drug Administration, and Comrade Qi Weiming, Director of the Zhejiang Medical Device Evaluation Center, visited Xingyue Biotechnology for a field investigation.
Accompanied by the management of the company, the leaders and experts of the Drug Administration visited the company's material research and development and testing platform one by one, and listened carefully to reports on the company's positioning, business achievements in the past decade, development plans, and problems and difficulties encountered in product development.
After listening to the report, the leaders of the State Administration for Market Regulation fully affirmed the company's various achievements, especially congratulated Xingyue Biotechnology for its huge breakthroughs in the high-end application of silk through its own technological innovation. At present, the development momentum of the enterprise is good, and the advantages of silk raw materials are obvious. The silk medical device series products developed will also greatly benefit patients after being launched.
Director Dong also stated that the main purpose of this research and visit activity is to understand the problems encountered by enterprises at the current stage, identify difficulties and pain points, and help enterprises grow rapidly. In this survey, the Drug Administration provided detailed guidance on the classification, performance indicators, clinical evaluation, and other aspects of the products that the company plans to develop. At the same time, we encourage enterprises to continue increasing their research and development investment, making silk into medical materials with Zhejiang characteristics, and becoming leaders in high-end medical equipment made of silk. We integrate the technology, professionalism, safety, and responsibility of enterprises into every detail, adding luster to the economic development of Zhejiang Province.
The company leaders and R&D team members participated in this exchange activity and expressed their gratitude for the guidance provided by the visiting leaders and experts; At the same time, it is stated that in the future, Xingyue Biotechnology will continue to take "technology regeneration health" as its mission, create outstanding technological capabilities, benefit people's health, and continuously strive to achieve "Chinese silk medical materials".
